Latest / Herbert Smith Freehills Kramer Podcasts / Insurance Bites EP6: D&O defence costs: the Court of Appeal decision in Liberty Managing Agency v Chedid
Transcript
- 0:09SPEAKER_01: Hello and welcome to another episode of Insurance Bytes, HSF Kramer's podcast on key insurance market developments.
- 0:16SPEAKER_01: I'm Hamish Hunter, a senior associate in the insurance and professional risks team, and I'm joined today by my colleague Kate Mann, who is also a senior associate in the team, to talk about the appeal in the Liberty Managing Agency and Chedded DO case.
- 0:33SPEAKER_01: But we rarely see reported judgments on them, let alone appeals.
- 0:37SPEAKER_01: So this one's particularly interesting, isn't it?
- 0:39SPEAKER_01: For those listening who have not read the blog article that you wrote on the first insulin's decision, and I'm sure that's no one, why don't you remind us of the facts and the decision?
- 0:48SPEAKER_00: Thanks, Hamish.
- 0:49SPEAKER_00: And yeah, it is uh rather unusual to get a reported DNO decision.
- 0:53SPEAKER_00: So I will admit I've been following this one rather closely, and um perhaps even to my own embarrassment dialing into the live stream of last Friday's Court of Appeal hearing.
- 1:02SPEAKER_00: So just on the facts, the case involved individuals, so former directors of PetroFact Limited, who are facing serious criminal charges under the Bribery Act and allegations of fraud.
- 1:14SPEAKER_00: Uh they deny the allegations and have sought cover, as one might expect, uh, for their defense costs associated with defending those criminal proceedings under their DO insurance policy, which sums I might add are, as you would expect, significant.
- 1:29SPEAKER_00: So interestingly, here the primary policy has been responding and has now been exhausted, I understand, to the tune of 30 million pounds, triggering the attachment of the excess policy.
- 1:40SPEAKER_00: And it's those excess insurers who have very recently purported to avoid the policy on the basis of allegations of fraudulent misrepresentation and non-disclosure in the placement of that policy.
- 1:53SPEAKER_00: And indeed, they've brought declaratory proceedings to that effect.
- 1:57SPEAKER_00: The position of the insured individuals was that the policy, on its express terms, requires the insurers to fund their defence cost until the fraudulent conduct is established, if indeed it is.
- 2:09SPEAKER_01: And indeed, most policyholders who are familiar with DNA insurance government would see that as a sort of ordinary, usual position.
- 2:16SPEAKER_00: I mean, that's exactly right, Hamish.
- 2:18SPEAKER_00: And policyholders will recognise that kind of final adjudication language, as it's often referred to, found in conduct exclusions that you see in DNO policies.
- 2:27SPEAKER_00: But in addition to that, the insurer's right to avoid the policy on the basis of fraudulent misrep or non-disclosure was also tempered by an equivalent provision that insurers' right to avoid only arose, quote, where such fraudulent conduct is established by a final decision of a court, tribunal, or regulator, or by a formal written admission of the insured.
- 2:49SPEAKER_00: And that language mirrored the language that that same policy had in its conduct exclusion.
- 2:54SPEAKER_01: So insurers not only had to wait to deny colour under the conduct exclusion, but if they wanted to avoid the policy entirely, they also had to wait.
- 3:02SPEAKER_00: Yeah, that's what was argued.
- 3:05SPEAKER_01: So how did insurers try to overcome that language in the policy?
- 3:08SPEAKER_00: So they argued that avoidance is a self-help remedy that insurers can invoke themselves without needing a court to approve it, and that the concluding words at the end of the clause that I just uh read out were surplusage and simply reflected the uncontroversial opinion position, they say, that an insurer who avoids must ultimately establish its case at trial.
- 3:31SPEAKER_00: And the insurers also argued from a public policy perspective that no clause in a policy can protect an insured or indeed allow them to benefit from the consequences of their own fraud.
- 3:44SPEAKER_01: Yes.
- 3:45SPEAKER_01: And I think it's fair to say that in short, Mr.
- 3:47SPEAKER_01: Justice Jacobs at first instance wasn't persuaded by those arguments.
- 3:52SPEAKER_00: Yeah, exactly.
- 3:53SPEAKER_00: The court held that on the construction point, uh, whilst the clause did represent a removal of insurers' rights at common law to exercise the so-called self-help remedy of avoidance, that the wording was sufficiently clear to do that, and that the words used imposed a condition on the insurer's avoidance rights.
- 4:12SPEAKER_00: He also noted that it made good commercial sense because the commercial purpose, as we know, of a DNA no insurance policy, is to provide defence cost funding to fight allegations just like these.
- 4:23SPEAKER_01: And that's related to the point he made about insurers' position risking being a self-fulfilling prophecy.
- 4:29SPEAKER_01: So if insurers withdraw defence cost funding, it actually increases the risk that the insured's defence fails, which in turn strengthens insurers' basis for not paying.
- 4:39SPEAKER_01: That all does seem to run against the point of the DNA insurance product.
- 4:44SPEAKER_00: Yes, quite.
- 4:45SPEAKER_00: And and on the public policy arguments, the court held that there's just no English authority, that there is a rule of public policy that prevents parties from agreeing that insurers are to fund the defence of fraud and similar allegations before such allegations are in fact proved.
- 5:01SPEAKER_00: Um and as to whether a party is being permitted to benefit from their own fraud, I mean the difficulty with that submission is of course that it's premised upon fraud being made out.
- 5:11SPEAKER_00: So that commercial risk allocation framework in the intervening period while the allegations are being contested, um, was essentially a part, and in my view, a key part, of the bargain that they had expressly struck.
- 5:24SPEAKER_01: So overall, in a first instance, I think we think that's a positive outcome for policyholders and some useful judicial commentary on how this kind of wording is supposed to operate, and I think helpfully in line with how most policyholders thought it did.
- 5:39SPEAKER_01: What arguments did insurers raise on the appeal?
- 5:43SPEAKER_00: Insurers focused on the right to avoid being a common law right that operates as a self-help remedy rather than one that's positively granted by the court.
- 5:51SPEAKER_00: A construction argument that needing to establish the fraud did not necessarily mean establish judicially and didn't therefore restrict their avoidance rights.
- 6:00SPEAKER_00: And again, public policy arguments against a party not being permitted to escape from the consequences of their own fraud.
- 6:06SPEAKER_01: And the insureds?
- 6:08SPEAKER_00: In broad overview, their case was that the clause contained clear contractual words setting out the sequence of events and that insurers cannot avoid until the conduct has been established.
- 6:19SPEAKER_00: They said it was essentially a timing point.
- 6:22SPEAKER_01: Interesting.
- 6:23SPEAKER_01: And excitingly, Kate, we we got a decision at the end of the hearing.
- 6:27SPEAKER_00: We did.
- 6:28SPEAKER_00: After just a short period of deliberation, the court returned to announce that it was to dismiss the insurer's appeal with reasons to follow in the usual way.
- 6:36SPEAKER_00: So we do know the outcome, and that is that the first instance judgment stands, but we don't yet have the proper precise reasons on hand.
- 6:43SPEAKER_01: Well, I'll certainly be interested to read the court's full reasoning when it comes, no doubt very shortly.
- 6:48SPEAKER_01: And on the point of timing and knowing the outcome, a final point worth mentioning, I think, Kate, is just how efficiently this has all been handled by both the High Court and the Court of Appeal.
- 6:59SPEAKER_00: Absolutely, Hamish.
- 7:00SPEAKER_00: I was only going to mention the same thing.
- 7:01SPEAKER_00: The High Court case proceeded as an expedited trial on the basis of agreed facts with no factual or expert evidence, uh, with a one-day hearing and a judgment handed down just two days later in September of this year.
- 7:13SPEAKER_00: And that followed uh the purported avoidance in only early August.
- 7:17SPEAKER_01: That's incredible.
- 7:19SPEAKER_00: And now, you know, we've got just some six weeks later, it's been in the Court of Appeal with a judgment already given with reasons to follow.
- 7:25SPEAKER_00: So I think overall it does show that the English courts recognise the seriousness of these issues and the precariousness of the insured's position.
- 7:33SPEAKER_01: Yeah, very good advocate for the English courts indeed.
- 7:36SPEAKER_01: Thank you, Kate.
- 7:37SPEAKER_01: That's been interesting and enlightening.
- 7:38SPEAKER_01: Uh, and no doubt we will be doing something when the Court of Appeal gives its reason in due course.
- 7:43SPEAKER_01: So stay tuned.
- 7:44SPEAKER_01: Thanks very much, Hamish.
- 7:45SPEAKER_00: Watch this face.